1. Home >
  2. M&A >
  3. Add-on Acquisition >
  4. Luxembourg >
  5. Azurity Pharmaceuticals Acquires Covis Pharma

M&A Deal Summary

Azurity Pharmaceuticals Acquires Covis Pharma

On March 14, 2025, Azurity Pharmaceuticals acquired life science company Covis Pharma from Apollo Global Management

Acquisition Highlights
  • This is Azurity Pharmaceuticals’ 4th transaction in the Life Science sector.
  • This is Azurity Pharmaceuticals’ 1st transaction in Luxembourg.

M&A Deal Summary
Date 2025-03-14
Target Covis Pharma
Sector Life Science
Buyer(s) Azurity Pharmaceuticals
Sellers(s) Apollo Global Management
Deal Type Add-on Acquisition

Target

Covis Pharma

Luxembourg, Luxembourg
Covis Pharma is a global specialty pharmaceutical company that markets therapeutic solutions for patients with life-threatening conditions and chronic illnesses. Covis is focused on marketing and distributing an array of branded products used to treat chronic and life-threatening medical issues and improve patient outcomes in various therapeutic areas including respiratory, cardiovascular, gastroenterology, and central nervous system diseases. Covis Pharma was founded in 2011 and is based in Luxembourg, Luxembourg.

Search 206,010 Deals Now

SEARCH BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Try For Free 7-Day Free Trial

Buyer(S) 1

Buyer

Azurity Pharmaceuticals

Woburn, Massachusetts, United States
Category Company
Founded 1998
Sector Life Science
DESCRIPTION

Azurity Pharmaceuticals is a privately held, specialty pharmaceutical company focusing on the development and commercialization of value-added proprietary drug products and technologies in the prescription compounding sector of the pharmaceutical industry. Azurity Pharmaceuticals was founded in 1998 and is based in Woburn, Massachusetts.

DEAL STATS #
Overall 4 of 4
Sector: Life Science M&A 4 of 4
Type: Add-on Acquisition M&A Deals 4 of 4
Country: Luxembourg M&A 1 of 1
Year: 2025 M&A 1 of 1
PREVIOUS DEAL
DATE TARGET DEAL TYPE VALUE
2023-09-27 Slayback Pharma

Princeton, New Jersey, United States

Slayback Pharma is a specialty pharmaceutical company focused on developing, manufacturing, and sourcing complex generic pharmaceutical products, with a specific emphasis on complex injectables and other non-solid oral products. Slayback Pharma was founded in 2011 and is based in Princeton, New Jersey.

Buy -

Seller(S) 1

SELLER

Apollo Global Management

New York, New York, United States

Investor Investor Investor Investor Investor

Category Asset Manager
Founded 1990
PE ASSETS 45.0B USD
Size Mega
Type Sector Agnostic
DESCRIPTION

Apollo Global Management is a global alternative investment firm. The Firm segments its activity between private equity, capital markets, real estate, and publicly traded investment funds. Within private equity, Apollo targets traditional buyouts, distressed situations, as well as minority investments to help companies make acquisitions or fund other needs. Sectors of interest include chemicals, commodities, consumer/retail, distribution, transportation, financial services, business services, manufacturing, industrial, media/cable/leisure, packaging, and satellite/wireless. Apollo's geographic coverage spans Europe, North America, and Asia. Apollo manages publicly traded Apollo Investment Corporation, which provides equity and junior capital to middle-market companies, as well as Apollo Commercial Real Estate Finance, Inc. Apollo Global Management was formed in 1990 and is based in New York City.

DEAL STATS #
Overall 68 of 68
Sector: Life Science M&A 1 of 1
Type: Add-on Acquisition M&A Deals 22 of 22
Country: Luxembourg M&A 1 of 1
Year: 2025 M&A 1 of 1
PREVIOUS DEAL
DATE TARGET DEAL TYPE VALUE
2025-02-12 Bold Production Services

Houston, Texas, United States

Bold Production Services provides high quality flowback and early production equipment to oil and gas operators. The company also provides consulting services and field support. Bold Production Services was founded in 2013 and is based in Houston, Texas.

Buy -
FOLLOWING DEAL
DATE TARGET DEAL TYPE VALUE
2025-03-19 OEG

Aberdeen, United Kingdom

OEG provides core services across the offshore energy ecosystem, delivering development and operations solutions to oil & gas (O&G) and wind end markets. OEG is based in Aberdeen, Scotland.

Buy -
Mergr

Product

Company

Legal